VENTURE CAPITAL POST

☰

Citi analyst

⌂Back To Homepage Subscribe To RSS Feed
 Breaking News
  

Bristol-Myers Squibb to exit diabetes joint venture - Citi analyst

An announcement made last Thursday of a realignment in priority drug research projects prompted Citi analyst to advise shareholders of a possible interest divestment in diabetes drug joint venture between Bristol-Myers Squibb and AstraZeneca.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Most Popular

Editor's pick

Must Read

 Breaking News
  
© 2022 Copyright Venture Capital Post. All Rights reserved.
Real Time Analytics